BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11831644)

  • 1. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets.
    Grossman D; Altieri DC
    Cancer Metastasis Rev; 2001; 20(1-2):3-11. PubMed ID: 11831644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma.
    Satyamoorthy K; Bogenrieder T; Herlyn M
    Trends Mol Med; 2001 May; 7(5):191-4. PubMed ID: 11325619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma.
    Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
    Oncol Rep; 2008 Aug; 20(2):271-7. PubMed ID: 18636186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bcl-2 and survivin levels in melanoma.
    Tas F; Duranyildiz D; Argon A; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2004 Dec; 14(6):543-6. PubMed ID: 15577328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma resistance gene identified.
    Bond T
    Biomark Med; 2013 Apr; 7(2):199. PubMed ID: 23667941
    [No Abstract]   [Full Text] [Related]  

  • 7. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
    Zhang H
    Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and melanoma chemoresistance.
    Soengas MS; Lowe SW
    Oncogene; 2003 May; 22(20):3138-51. PubMed ID: 12789290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in human melanoma: mechanisms and therapeutic opportunities.
    Röckmann H; Schadendorf D
    Onkologie; 2003 Dec; 26(6):581-7. PubMed ID: 14709935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human melanoma: drug resistance.
    Helmbach H; Sinha P; Schadendorf D
    Recent Results Cancer Res; 2003; 161():93-110. PubMed ID: 12528802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
    Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Arch Ophthalmol; 2005 May; 123(5):654-61. PubMed ID: 15883285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
    Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis and potential role of survivin in cancer diagnosis and therapy.
    Altieri DC
    Trends Mol Med; 2001 Dec; 7(12):542-7. PubMed ID: 11733216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
    Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
    Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming melanoma drug resistance through metabolic targeting?
    Smalley KS
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):793-5. PubMed ID: 24152044
    [No Abstract]   [Full Text] [Related]  

  • 17. Melanoma never says die.
    Haass NK; Schumacher U
    Exp Dermatol; 2014 Jul; 23(7):471-2. PubMed ID: 24684560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
    Porebska I; Sobańska E; Kosacka M; Jankowska R
    Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutics, chemoresistance and the management of melanoma.
    Rass K; Hassel JC
    G Ital Dermatol Venereol; 2009 Feb; 144(1):61-78. PubMed ID: 19218912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.
    Grossman D; Kim PJ; Blanc-Brude OP; Brash DE; Tognin S; Marchisio PC; Altieri DC
    J Clin Invest; 2001 Oct; 108(7):991-9. PubMed ID: 11581300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.